116 related articles for article (PubMed ID: 28903448)
1. Positive expression of Y-box binding protein 1 and prognosis in non-small cell lung cancer: a meta-analysis.
Jiang L; Yuan GL; Liang QL; Zhang HJ; Huang J; Cheng SA; Peng XX
Oncotarget; 2017 Aug; 8(33):55613-55621. PubMed ID: 28903448
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Zhao S; Qiu Z; He J; Li L; Li W
Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis.
Chen Y; Wang T; Wang W; Hu J; Li R; He S; Yang J
Oncotarget; 2017 Sep; 8(37):62537-62544. PubMed ID: 28977967
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
6. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
7. Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Tan Z; Yang C; Zhang X; Zheng P; Shen W
Oncotarget; 2017 Sep; 8(37):60954-60961. PubMed ID: 28977837
[TBL] [Abstract][Full Text] [Related]
8. Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.
Huang H; Li J; Hu WJ; Chen MH; Chen SS; Chen C; Luo HQ; Zhou KY; Liu XG; Li XY
J BUON; 2018; 23(4):1185-1194. PubMed ID: 30358230
[TBL] [Abstract][Full Text] [Related]
9. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis.
Huang G; Zhang J; Wang X; Chen Y; Liu D; Guo S
Onco Targets Ther; 2019; 12():3609-3617. PubMed ID: 31190863
[No Abstract] [Full Text] [Related]
12. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
Shibahara K; Sugio K; Osaki T; Uchiumi T; Maehara Y; Kohno K; Yasumoto K; Sugimachi K; Kuwano M
Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis.
Meng W; Liao Y; Chen J; Wang Y; Meng Y; Li K; Xiao H
J Thorac Dis; 2021 Jul; 13(7):4281-4300. PubMed ID: 34422356
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
16. Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.
Ruan H; Hu S; Zhang H; Du G; Li X; Li X; Li X
Oncotarget; 2017 Dec; 8(68):113163-113173. PubMed ID: 29348895
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
Nishio S; Ushijima K; Yamaguchi T; Sasajima Y; Tsuda H; Kasamatsu T; Kage M; Ono M; Kuwano M; Kamura T
Gynecol Oncol; 2014 Mar; 132(3):703-8. PubMed ID: 24486603
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
